Literature DB >> 2208656

Measurement of polyethylene glycol 400 in urine by direct-injection high-performance liquid chromatography.

G O Young1, D Ruttenberg, J P Wright.   

Abstract

We describe a new "high-performance" liquid chromatographic (HPLC) method for estimating polyethylene glycol 400 (PEG 400) in urine. Direct injection of diluted urine samples onto the column eliminates the necessity for lengthy preparative steps, resulting in considerable saving of both time and chemicals. High analytical recoveries (94-102%) and a rapid rate of analysis are achieved. Results vary linearly with concentrations from 0.2 to 1.6 g/L and the six major components can be individually quantified precisely at all concentrations in this range. This method shows better sample recovery, sensitivity, and reproducibility than does a previously described method. The increased sensitivity should allow the use of lower oral doses of polyethylene glycol 400 in future studies of intestinal permeability.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2208656

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  PEG-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteers.

Authors:  D Ruttenberg; G O Young; J P Wright; S Isaacs
Journal:  Dig Dis Sci       Date:  1992-05       Impact factor: 3.199

2.  Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine.

Authors:  Abdul W Basit; Fridrun Podczeck; J Michael Newton; Wendy A Waddington; Peter J Ell; Larry F Lacey
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

Review 3.  Current status of in vivo bioanalysis of nano drug delivery systems.

Authors:  Tingting Wang; Di Zhang; Dong Sun; Jingkai Gu
Journal:  J Pharm Anal       Date:  2020-05-16

4.  Quantification of Polyethylene Glycol 400 Excreted in the Urine by MALDI-TOF Mass Spectrometry.

Authors:  Ákos Kuki; Mahir Hashimov; Tibor Nagy; Csaba Tóth; Miklos Zsuga; Sándor Kéki
Journal:  Pharmaceutics       Date:  2022-06-24       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.